Kanohar Electricals
FinMinutes Deep Business Model & Edge
Kanohar Electricals Limited is a leading domestic manufacturer of power transmission transformers and a turnkey EPC solutions provider in India. Established in 1972, the company owns and operates two automated manufacturing facilities in Meerut, Uttar Pradesh, specializing in high-voltage power transformers up to 500 MVA, 400 kV.
What this company actually does — full breakdown ▾
Kanohar Electricals Limited, established in 1972, is a prominent domestic player in India's power transmission infrastructure sector, specializing in the design, manufacture, and installation of power transformers. The company owns and operates two automated manufacturing facilities in Meerut, Uttar Pradesh, consisting of the Rithani facility (operational since 1983, manufacturing distribution and small power transformers up to 25 MVA, 66 kV) and the Gangol facility (operational since 1997, manufacturing large power transformers up to 500 MVA, 400 kV) with an aggregate annual installed capacity of 19,200 MVA as of March 31, 2026. The company's product portfolio covers power, distribution, traction, and Scott-connected transformers, catering to high-growth strategic sectors such as state and central utilities (GETCO, Rajasthan Transco, PGCIL), Indian Railways, and private EPC contractors. The firm operates under a tender-driven, order-based model, with government entities accounting for 93.62% of its ₹ 1,818.32 crore order book as of Fiscal 2026. Kanohar is highly backward-integrated, producing critical components like transformer tanks and radiators indigenously, which reduces third-party dependencies, ensures quality control, and achieves faster delivery lead times compared to its peers.
- Transformer Manufacturing Business — Specializes in manufacturing distribution, power, traction, and special-purpose Scott transformers up to 500 MVA, 400 kV. This is the company's core segment, contributing 83.43% (₹ 545.51 crore) of revenue from operations in Fiscal 2026.
- EPC Business — Provides engineering, procurement, and construction services for substation construction and transmission line installations on a turnkey basis. Contributed 16.44% (₹ 107.50 crore) of revenue from operations in Fiscal 2026.
Kanohar's competitive moat is driven by high technical barriers to entry and strict pre-qualification approvals. The company is one of only five players in India with short-circuit test certification for 500 MVA 400 kV transformers, and one of four certified by RDSO to manufacture 100 MVA 132 kV Scott-connected transformers. Additionally, its robust backward-integrated facilities for in-house manufacturing of transformer tanks and radiators act as key cost and lead-time advantages over competitors.
The Offer
Follow the Money — Use of Proceeds
- Funding the capital expenditure requirements of our Company towards: (i) purchase of new machinery and equipment for our Gangol Manufacturing Facility; (ii) civil construction and development of a New Office Building at Gangol; and (iii) setting up on-grid rooftop solar power plants and purchasing Electric Vehicles. — ₹64.18 cr
- Funding incremental working capital requirements of our Company — ₹155.00 cr
- General corporate purposes
Valuation at the Offer Price
The filing does not print a single headline multiple, so this one is ours: the upper band divided by the latest restated earnings per share — the same arithmetic the “Basis for the Offer Price” section performs. It is struck on pre-issue earnings, so the post-issue figure will differ once the fresh capital is deployed. The peer group is the one the filing itself names. A premium is not the same thing as expensive and a discount is not the same thing as cheap — the peer table and the reasons sit further down this page.
FinMinutes IPO Score — How It's Built
Transparent, deterministic, computed from the filing — not an opinion. Open any component below to see exactly what it measures and what it is worth. Components with no disclosed input are dropped from the weighting entirely rather than held at an invented neutral, because a constant inside a weighted average is not neutral — it quietly drags every score toward the middle. Weighted across 6 live components.
100% of the designed weighting had real data behind it on this issue. A lower coverage figure does not mean a worse company — it means we are standing behind less of the picture, and you should read the findings below rather than the headline number.
How this is measured12%
Whether fresh capital actually enters the business. A predominantly offer-for-sale issue is marked down ONLY when the financials are weak. A profitable, cash-rich company selling down is treated as neutral, not penalised, because it does not need the money.
How this is measured12%
What changed between the draft prospectus and the final one. A period roll-forward or a refreshed industry report is expected and scores neutral. A statutory auditor replaced mid-process, a prior year restated, an offer-for-sale expanded late, new statutory dues disclosed, or a risk factor quietly removed all score against. Where only one of the two documents has been read, this component is dropped from the weighting rather than guessed.
How this is measured32%
Driven by the models battery run on the filing's own restated numbers: the Piotroski fundamental tests (scored out of those we could actually run), the Altman Z-double-prime solvency zone, and the direction of profit across the disclosed period. It is not a single yes/no on last year's profit.
How this is measured10%
The post-issue earnings multiple against the peer median disclosed in the filing. A discount to the median scores well and a premium scores badly. When the filing does not disclose comparable peer multiples, this component is dropped from the weighting rather than held at a made-up neutral.
How this is measured6%
A proxy for syndicate strength, based today only on how many lead managers are on the issue: 75 where three or more banks are involved, 60 otherwise. We have not built a bank-by-bank track record, so treat this as a rough signal. When the filing does not disclose the syndicate, this component is dropped from the weighting rather than guessed.
How this is measured28%
Starts at 100 and loses points for every material finding: 12 for a flagged finding, 4 for a noted one. Two kinds feed it. DERIVED findings are computed from the filed numbers against stated thresholds — operating cash negative while profit is positive, related-party revenue above 15% of total, revenue rising while profit falls, goodwill above 30% of net worth, receivables growing more than 1.3x faster than sales, cash below half of short-term debt. Those are reproducible: the same filing gives the same answer every time, and the rule is printed beside the finding. READ findings come from the forensic sweep of the notes. Contingent liabilities, related-party intensity, customer concentration, litigation, auditor qualifications, statutory dues, promoter funding. Findings that record the ABSENCE of a problem — no litigation pending, an unmodified audit opinion — deduct nothing. This is the component our forensic read drives directly, and it moves most between companies.
3-Year Financial & Growth Trend
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| Revenue (₹ Cr) | 653.839 | 450.612 | 276.69 |
| Net Profit (₹ Cr) | 129.733 | 65.118 | 17.755 |
| PAT Margin | 19.84% | 14.45% | 6.42% |
Revenue Breakdown
- Transformer Manufacturing Business: 83.43%
- EPC solutions for transmission lines: 9.69%
- EPC solutions for substations: 6.75%
- Other operating revenue: 0.13%
Market Context
NOT part of the FinMinutes ScoreThe Score above is what the filing says. Everything in this box is what the crowd says. We keep them apart on purpose — every other site blends the two and calls the result a rating. Demand is real information, but it is information about the market, not about the company, and it changes by the hour while the company does not.
Subscription is low early in a book and high at the end, because most bids arrive in the final hours. A number read on day one says more about the clock than the company — which is precisely why it is not in the Score. GMP is unofficial, unregulated, and easily moved. Neither is a recommendation.
Deep Financials
Revenue, EBITDA and profit are what every listing site prints. Below are the full restated statements as disclosed, the ratios we compute from them, and a DuPont decomposition of the return on equity. A prospectus carries three years, not ten — that is the document’s ceiling, and within it we go as deep as it allows.
Income StatementThe profit and loss as filed, then what we derive from it — kept apart.
Statutory order, exactly as restated in the filing. Finance cost and depreciation sit inside Total Expenses under Ind AS, which is why they are listed among the expense lines here rather than below the total. The expense rows sum to the total. Rows the filing does not disclose separately are omitted rather than left blank.
| Income Statement — as filed (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Revenue from Operations | 653.84 | 450.61 | 276.69 |
| Other Income | 9.02 | 6.68 | 4.43 |
| Total Income | 662.86 | 457.30 | 281.12 |
| Cost of Materials Consumed | 371.38 | 220.00 | 150.63 |
| Purchases of Stock-in-Trade | 75.10 | 36.68 | 81.45 |
| Changes in Inventories | -46.86 | 47.45 | -35.06 |
| Employee Benefit Expense | 40.61 | 23.89 | 23.19 |
| Finance Cost | 12.91 | 9.40 | 6.48 |
| Depreciation & Amortisation | 2.96 | 2.88 | 3.15 |
| Other Expenses | 33.19 | 29.20 | 25.42 |
| Total Expenses | 489.29 | 369.50 | 255.25 |
| Profit Before Exceptional Items and Tax | 173.58 | 87.79 | 25.87 |
| Profit Before Tax | 173.58 | 87.79 | 25.87 |
| Tax Expense | 43.84 | 22.67 | 8.11 |
| Profit After Tax | 129.73 | 65.12 | 17.76 |
| Other Comprehensive Income | -0.02 | -0.11 | -0.15 |
| Total Comprehensive Income | 129.71 | 65.01 | 17.61 |
| EPS - Basic | 17.43 | 8.75 | 2.39 |
| EPS - Diluted | 17.43 | 8.75 | 2.39 |
Balance SheetWhat the company owns, owes, and is worth on paper.
| Balance Sheet (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Share Capital | 14.89 | 4.02 | 4.02 |
| Reserves & Surplus | 357.95 | 239.12 | 174.11 |
| Net Worth | 372.84 | 243.13 | 178.12 |
| Long-term Borrowings | 14.44 | 6.03 | 0.61 |
| Short-term Borrowings | 24.60 | 26.23 | 41.47 |
| Total Borrowings | 39.04 | 32.27 | 42.08 |
| Trade Payables | 100.04 | 72.52 | 59.12 |
| Current Liabilities | 214.58 | 170.80 | 131.78 |
| Total Liabilities | 241.09 | 188.93 | 144.74 |
| Property, Plant & Equipment | 30.75 | 29.86 | 23.91 |
| Capital Work in Progress | 14.04 | 1.26 | 0.00 |
| Intangible Assets | 0.64 | 1.19 | 1.50 |
| Investments | 0.00 | 0.00 | 0.00 |
| Inventories | 114.15 | 43.43 | 83.70 |
| Trade Receivables | 210.79 | 194.78 | 86.99 |
| Cash & Equivalents | 0.00 | 0.26 | 0.06 |
| Current Assets | 537.08 | 375.17 | 229.08 |
| Total Assets | 613.93 | 432.07 | 322.86 |
Cash FlowWhere the cash actually went. Often the most honest statement of the three.
| Cash Flow (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Net Cash from Operating Activities | 25.84 | 79.38 | -16.32 |
| Capital Expenditure | 14.82 | 10.20 | 1.96 |
| Net Cash from Investing Activities | -21.95 | -61.50 | -12.99 |
| Net Cash from Financing Activities | -4.15 | -17.69 | 12.14 |
| Net Change in Cash | -0.25 | 0.20 | -1.72 |
Ratio AnalysisProfitability, leverage, liquidity, efficiency and earnings quality — computed by us.
Every ratio below is computed by us from the line items the company disclosed — not copied from anywhere. The arithmetic is standard; the point is that somebody actually did it. Blank cells mean the filing did not disclose the inputs, and we would rather show a gap than invent a number.
| Ratio | FY26 | FY25 | FY24 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin (%) | 28.6 | 21.9 | 12.6 |
| EBIT Margin (%) | 28.1 | 21.3 | 11.5 |
| PAT Margin (%) | 19.8 | 14.5 | 6.4 |
| Return on Equity (%) | 34.8 | 26.8 | 10 |
| Return on Capital Employed (%) | 45.3 | 35.3 | 14.7 |
| Return on Assets (%) | 21.1 | 15.1 | 5.5 |
| Leverage | |||
| Debt / Equity (x) | 0.1 | 0.13 | 0.24 |
| Net Debt / EBITDA (x) | 0.21 | 0.32 | 1.18 |
| Interest Coverage (x) | 14.45 | 10.34 | 4.99 |
| Liquidity | |||
| Current Ratio (x) | 2.5 | 2.2 | 1.74 |
| Quick Ratio (x) | 1.97 | 1.94 | 1.1 |
| Efficiency | |||
| Asset Turnover (x) | 1.07 | 1.04 | 0.86 |
| Receivable Days | 118 | 158 | 115 |
| Inventory Days | 64 | 35 | 110 |
| Payable Days | 56 | 59 | 78 |
| Cash Conversion Cycle (days) | 126 | 134 | 147 |
| Quality of Earnings | |||
| Operating Cash Flow / PAT (x) | 0.2 | 1.22 | -0.92 |
| Accruals Ratio (%) | 16.9 | -3.3 | 10.6 |
| Capex / Depreciation (x) | 5.01 | 3.54 | 0.62 |
DuPont DecompositionWhy the return on equity is what it is: margin, efficiency, or leverage.
A headline return on equity tells you what. The DuPont decomposition tells you why — whether the return is earned through margin, through asset efficiency, or simply through leverage. Two companies can post an identical ROE for opposite reasons, and only one of them is safe.
| Component | FY26 | FY25 | FY24 |
|---|---|---|---|
| Net Margin (PAT / Revenue) | 19.8% | 14.5% | 6.4% |
| Asset Turnover (Revenue / Assets) | 1.07x | 1.04x | 0.86x |
| Equity Multiplier (Assets / Net Worth) | 1.65x | 1.78x | 1.81x |
| = Return on Equity | 34.8% | 26.8% | 10% |
| Tax Burden (PAT / PBT) | 0.75x | 0.74x | 0.69x |
| Interest Burden (PBT / EBIT) | 0.93x | 0.9x | 0.8x |
| Operating Margin (EBIT / Revenue) | 28.5% | 21.6% | 11.7% |
Computed from the disclosed statements. Where the filing omits an input, the row is left blank rather than estimated.
Quality of EarningsWhat the statements say when you read them against each other.
What the statements say once you read them against each other. These are observations, not verdicts — every one is arithmetic on the numbers the company itself disclosed, and each is stated so you can go and check it in the filing.
- Operating cash flow was only 0.2x reported profit in FY26. Less than half of the profit on the income statement arrived as cash.
- Between FY24 and FY26 revenue grew 136% while profit grew 631%. Profit expanding at several times the rate of revenue is not automatically a concern — operating leverage does exactly this — but it is worth confirming from the filing whether the gap comes from genuine margin expansion or from one-off items.
- Interest coverage was 14.45x in FY26. Debt servicing is comfortably covered by operating profit.
Forensic ModelsBeneish, Altman and Piotroski — plus our own final-year check.
Beneish M-Score
M = -1.3An eight-variable model built to detect earnings manipulation, and built to run on exactly two consecutive years — which is what a prospectus gives us. It belongs here more than anywhere: a company about to list has the maximum possible incentive to have dressed up the very years it is about to show you. A score above −1.78 is the threshold at which the model says the accounts merit a closer look. It is a screening signal, not an accusation, and it was calibrated on listed companies elsewhere. Read the eight components, not just the total.
| Component | Value | What it captures |
|---|---|---|
| DSRI Days Sales in Receivables Index (Receivables_t / Sales_t) / (Receivables_t-1 / Sales_t-1) | 0.746 | Above 1 means receivables grew faster than sales. Revenue may be being recognised ahead of collection. |
| GMI Gross Margin Index GrossMargin_t-1 / GrossMargin_t | 1.185 | Above 1 means margins deteriorated. A firm with worsening prospects has more incentive to manipulate. |
| AQI Asset Quality Index AQ_t / AQ_t-1, where AQ = 1 - (CurrentAssets + PPE) / TotalAssets | 1.2 | Above 1 means a rising share of assets is soft (neither current nor fixed) — capitalised costs can hide here. |
| SGI Sales Growth Index Sales_t / Sales_t-1 | 1.451 | Growth is not manipulation. But high-growth firms face more pressure to keep the streak going. |
| DEPI Depreciation Index DepRate_t-1 / DepRate_t, where DepRate = Dep / (Dep + PPE) | 1.004 | Above 1 means assets are being depreciated more slowly — a quiet way to lift reported profit. |
| SGAI SG&A Index (SGA_t / Sales_t) / (SGA_t-1 / Sales_t-1), SGA proxied as employee cost + other expenses | 0.958 | A proxy, because filings rarely break out SG&A cleanly. Read it as a direction, not a precise figure. |
| LVGI Leverage Index Leverage_t / Leverage_t-1, where Leverage = (CurrentLiab + LongTermDebt) / TotalAssets | 0.911 | Above 1 means leverage rose. Debt covenants create pressure to hit numbers. |
| TATA Total Accruals to Total Assets (PAT - CashFromOperations) / TotalAssets | 0.1692 | The gap between reported profit and cash generated. The single heaviest term in the model — and the one that catches profit that never became cash. |
This score is driven primarily by the sales-growth term (SGI). Growth is the one variable in this model that is not itself a manipulation signal — the model treats rapid growth as pressure to keep the streak going, not as evidence of anything. A company that grew revenue several-fold will read high here for that reason alone. The variable that speaks to manipulation directly is TATA (accruals — profit that did not become cash); read that one, and the receivables trend, rather than the headline M.
M = -1.3, above the −1.78 threshold. On this model the accounts merit closer reading. That is a prompt to go to the filing, not a conclusion about it.
Altman Z″-Score (emerging markets)
Z″ = 12.26 · SafeA distress-prediction model. We use the Z″ variant deliberately: the original Z was calibrated on American manufacturers and misleads badly on Indian services companies. Above 2.6 is the safe zone, 1.1 to 2.6 is grey, below 1.1 is the distress zone. Like every model of its kind it is a screen, not a prophecy.
| X1 — Working Capital / Total Assets | 0.525 |
| X2 — Retained Earnings / Total Assets | 0.583 |
| X3 — EBIT / Total Assets | 0.304 |
| X4 — Net Worth / Total Liabilities | 1.547 |
| Z″ = 3.25 + 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4 | 12.26 |
Piotroski F-Score (adapted)
5 / 8Nine yes-or-no tests of fundamental strength — except we run eight. One of the original nine asks whether the company issued new shares, which is plainly absurd to ask of a company whose entire purpose at this moment is to issue shares. We drop that test and score out of eight, and we would rather tell you that than quietly fudge it.
- ✓Positive return on assets
- ✓Positive operating cash flow
- ✓Return on assets improving
- ✗Cash flow exceeds profit (quality of earnings)
- ✗Long-term leverage decreasing
- ✓Current ratio improving
- ✗Gross margin improving
- ✓Asset turnover improving
The Final-Year Check
oursNot from any textbook. The hockey stick in the last year before a filing is the oldest pattern in this business, and nobody publishes it. So we measure it: how the final disclosed year compares with the years behind it. Real acceleration looks exactly the same on the page as a flattering one — which is precisely why it is worth naming rather than assuming either way.
- Cash conversion fell sharply in the final year: operating cash flow was 0.2x profit in FY26, against 1.22x in FY25. Profit rose; the cash behind it did not follow at the same rate.
Ratios Nobody Prints
- Contingent liabilities / Net worth: 88.6%
Contingent liabilities of 330.27 cr against a net worth of 372.84 cr — 88.6% of what the company is worth on paper. These are obligations that sit off the balance sheet but could land on it. What they consist of matters as much as the size: a corporate guarantee to a subsidiary is a different animal from a disputed tax demand, and the filing says which. - Related-party revenue / Total revenue: 0%
0% of revenue in FY26 came from entities connected to the promoters. Revenue you sell to yourself is not the same as revenue you won in the market. - Cash / Short-term borrowings: 0x
Short-term borrowings of 24.60 cr against cash of 0.00 cr. Debt that must be refinanced within a year is only comfortable while lenders stay comfortable. - Promoter remuneration / PAT: 12.3%
Managerial remuneration to the promoter group was 15.93 cr against a profit of 129.73 cr. This is a legitimate cost — but it is also a route by which value leaves a company before it ever reaches a minority shareholder.
The Formula NotebookEvery number above, with the working shown. Check us.
Every number we publish, with the working shown. The formula, the same formula with this company’s actual figures put into it, the answer, and what it is for. Check us. That is the point.
PAT ÷ Net Worth129.73 ÷ 372.84What the company earned on the money shareholders have in it. The headline measure of return — and the one the DuPont section takes apart.
EBIT ÷ (Net Worth + Total Borrowings)186.48 ÷ (372.84 + 39.04) = 186.48 ÷ 411.88Return on ALL the capital in the business, borrowed as well as owned. Unlike ROE, it cannot be flattered by taking on debt.
EBITDA ÷ Revenue189.44 ÷ 653.84Operating profitability before the effects of debt, tax and depreciation. What the business earns from the act of trading.
Total Borrowings ÷ Net Worth39.04 ÷ 372.84How much the company has borrowed against what it owns. High is not automatically bad — ask whether the borrowing is being serviced comfortably.
EBIT ÷ Finance Cost186.48 ÷ 12.91How many times over operating profit covers the interest bill. Below about 2x, a meaningful share of what the business earns is going to lenders rather than owners.
(Trade Receivables ÷ Revenue) × 365(210.79 ÷ 653.84) × 365How long the company waits to be paid. Rising receivable days mean revenue is being booked faster than it is collected — which is where a great many accounting problems begin.
Inventory Days + Receivable Days − Payable Days64 + 118 − 56How long cash is tied up in the operating cycle before it comes back. The longer it is, the more working capital the business must fund.
Cash from Operations ÷ PAT25.84 ÷ 129.73Did the profit turn into cash? Profit is an opinion; cash is a fact. When this sits well below 1x for long, the two are drifting apart, and the filing is where you find out why.
(PAT − Cash from Operations) ÷ Total Assets(129.73 − 25.84) ÷ 613.93 = 103.89 ÷ 613.93The share of reported profit that exists on paper rather than in the bank. It is also the heaviest single term in the Beneish model, for good reason.
Price × Post-issue Shares₹632.00 × 74,430,866 sharesWhat the whole company is being valued at, if the issue prices at the top of the band.
Market Cap + Total Borrowings − Cash4,704.03 + 39.04 − 0.00What it would actually cost to buy the whole business: you take on its debt and you get its cash. This is the number a buyer cares about, and it is the reason a P/E on its own can mislead.
Enterprise Value ÷ EBITDA4,743.07 ÷ 189.44The multiple that includes debt. Two companies on the same P/E — one debt-free, one heavily borrowed — are not the same investment, and only this number tells you so.
Market Cap ÷ PAT4,704.03 ÷ 129.73The familiar multiple. Useful, but blind to debt — read it alongside EV/EBITDA, never instead of it.
EBIT × (1 − tax rate) ÷ (Net Worth + Debt − Cash)NOPAT ÷ Invested CapitalWhat the business earns on the capital actually at work in it. We do not compare this to a cost of capital: that would need a beta, an unlisted company has none, and inventing one would be theatre.
P/E ÷ trailing PAT growth (%)36.26 ÷ 99.2%PEG was designed for FORWARD growth. This one uses TRAILING growth, because that is all a prospectus gives us — and the final year before an IPO is very often the best year the company will have for a while. A low PEG here may say more about the timing of the filing than about the price. We show it because it was asked for; we show the growth denominator beside it so it cannot mislead you quietly.
Workspace
The post-issue share count is stated as “[•]” in this filing until final pricing, so we derive it: profit after tax divided by earnings per share gives the pre-issue count, and the fresh issue divided by the offer price gives the new shares. Everything below rests on that derivation. It is close, not exact.
The numbers are already loaded. Move the offer price and watch every multiple move with it. Set your own growth and margin and see what they imply two years out. These are your assumptions, not our forecast — we have no view on what this company will earn, and the moment we published one we would be doing something we are not registered to do. What we can do is put the arithmetic in front of you and get out of the way.
Price defaults to the top of the band. Margin defaults to what the company actually reported in FY26.
Projections are arithmetic on the inputs you typed. They are not a forecast, not a recommendation, and not a view on whether this offer is worth taking. Educational only.
Institutional Alpha: DRHP Deep Dive
The Indian power transmission and transformer manufacturing industry is experiencing steady expansion, driven by national grid upgrades, rural electrification programs, and renewable energy integration targets of 500 GW by 2030. The domestic transformer market has grown consistently, expanding from USD 3,691.40 million in CY19 to USD 4,944.90 million (₹ 46,803.48 crore) in CY25 at a CAGR of 5.0%, and is projected to accelerate to reach USD 6,854.20 million (₹ 64,874.96 crore) by CY30 at a CAGR of 6.7%. Growth is particularly robust in the extra-high voltage and ultra-high voltage segments, which are projected to grow at CAGRs of 9.3% and 8.9% respectively, creating sustained demand for certified local manufacturers like Kanohar.
Future Planning
Kanohar is planning to utilize ₹ 64.18 Crore of the IPO proceeds for capital expenditure at its Gangol facility, aimed at increasing transformer manufacturing capacity, automating its backward integration lines (tanks/radiators), installing rooftop solar plants (Rithani/Gangol), and purchasing Electric Vehicles to lower internal operating costs.
Source: p. 131, p. 211Competitive Position
The company holds a strong import-substitution position in EHV transformers. Being one of only five companies in India with short-circuit test certification for 500 MVA 400 kV power transformers and RDSO pre-qualification for Scott traction transformers creates an extensive competitive moat against low-tech local transformer players.
Source: p. 58, p. 133Execution Track Record
While Kanohar has a long operational history (since 1972), its project execution is vulnerable to public utility coordination. Its joint venture substation project with BSPTCL was debarred for execution delays and defects. Additionally, capacity utilization at the Rithani facility was extremely low (0.25%) as operations were diverted to R&D prototype development and extensive short-circuit validations.
Source: p. 14, p. 174, p. 175Shareholding, Syndicate & Leadership
Leadership & Skin in the Game
Leadership: Dinesh Singhal
Litigation: Outstanding litigation by the Company includes 5 tax proceedings and 1 material civil litigation (aggregate involved ₹ 6.153 Crore). Outstanding litigation against the Company includes 2 tax proceedings and 2 material civil litigations (aggregate involved ₹ 16.224 Crore). Outstanding litigations against Directors and Promoters are Nil.
Auditor / RPT Flags: Statutory Auditor under CARO 2020 Clause 3(ii)(b) issued negative comments regarding discrepancies in quarterly bank statements on working capital against books of accounts for FY26 and FY25. Predecessor Auditor in FY24 issued a negative comment under Clause 3(iv) regarding non-charging of interest on a loan, and Note 40 records excess managerial remuneration of ₹ 0.828 Crore in FY24 under Section 197.
Peers & Valuation
| Company | P/E | P/B | RoE | Margin |
|---|---|---|---|---|
| Hitachi Energy India Limited | — | — | 21.04 | EBITDA Margin: 15.37%, PAT Margin: 11.78% |
| Bharat Heavy Electricals Limited | — | — | 6.29 | EBITDA Margin: 6.93%, PAT Margin: 4.63% |
| Schneider Electric Infrastructure Limited | — | — | 31.81 | EBITDA Margin: 12.83%, PAT Margin: 7.31% |
| CG Power & Industrial Solutions Limited | 114.77 | — | 19.56 | EBITDA Margin: 13.09%, PAT Margin: 9.45% |
| Transformers & Rectifiers (India) Limited | 32.19 | — | 19.33 | EBITDA Margin: 15.27%, PAT Margin: 10.59% |
| GE Vernova T&D India Limited | 89.37 | — | 60.96 | EBITDA Margin: 27.13%, PAT Margin: 21.60% |
At the ₹632 upper band, the issue is priced at 36.3x earnings — a 59% discount to the peer median of 89.4x. This is the arithmetic of the price band against the peers the filing itself lists; it is not a view on whether the offer is worth taking.
🔍 Forensic Findings — What the Footnotes Say
Findings from across the filing — the notes, MD&A, related-party disclosures, contingent liabilities, CARO and litigation, alongside the risk section itself. Each carries where it was found, so you can see which were buried and which were disclosed. Findings marked derived are computed from the filed numbers against a stated rule, shown beside them.
Bihar State Power Transmission Company Limited (BSPTCL) issued an order dated February 23, 2026 debarring Kanohar (in joint venture with Aquarian Enterprises) from participating in future tenders for three years due to Project execution delays and defects. BSPTCL conditionally withdrew the debarment on May 14, 2026 subject to completing balance punch-point work by June 30, 2026 (which was completed on time).
p. 14, p. 117Statutory Auditor under CARO Clause 3(ii)(b) raised negative comments for FY26 and FY25 stating that quarterly returns/statements filed with banks for working capital limits do not agree with books of accounts. The company responded that project inventory is performed on customer sites and cannot be exactly reconciled.
p. 85, p. 119The company disclosed extensive historical non-compliances under the Companies Act, including improper Audit Committee constitution (noted by auditor in FY25), CSR committee constitution, NRC constitution, non-appointment of a woman director, delays in appointing independent directors, and secretarial audit lapses. Suo moto adjudication applications were filed on December 6, 2025, seeking RoC regularization.
p. 122, p. 237Promoter and Promoter Group remuneration (salary/benefits paid to Dinesh, Adesh, Vivek, Abhishek, Brijesh, etc.) skyrocketed from ₹ 0.410 Crore in FY25 to ₹ 1.593 Crore in FY26. This represents a ~288% increase in a single year, consuming 39.2% of the entire company's FY26 employee benefits expense (₹ 4.061 Crore).
p. 123During the year ended March 31, 2024, the Company paid remuneration to its Executive Directors (including commission) in excess of limits prescribed under Section 197 read with Schedule V of the Companies Act, 2013, by ₹ 0.828 Crore. This excess was subsequently regularized by obtaining shareholder approval via special resolution on June 28, 2025.
p. 37Historical secretarial and corporate records regarding share capital changes, sub-divisions/splits from ₹ 100 to ₹ 10 face value, and regulatory returns are untraceable. Practicing Company Secretary GDR & Partners LLP confirmed the records were lost after carrying out physical inspections.
p. 42The company relies heavily on a highly concentrated customer base, with its top 10 clients contributing 93.16% of FY26 revenue. Tenders awarded by central and state government entities accounted for 85.37% of FY26 revenues from operations.
p. 14, p. 117Outstanding litigation by the Company includes 5 tax proceedings and 1 material civil litigation (aggregate involved ₹ 6.153 Crore). Outstanding litigation against the Company includes 2 tax proceedings and 2 material civil litigations (aggregate involved ₹ 16.224 Crore). Outstanding litigations against Directors and Promoters are Nil.
p. 37, p. 41, p. 123, p. 148, p. 185Statutory Auditor under CARO 2020 Clause 3(ii)(b) issued negative comments regarding discrepancies in quarterly bank statements on working capital against books of accounts for FY26 and FY25. Predecessor Auditor in FY24 issued a negative comment under Clause 3(iv) regarding non-charging of interest on a loan, and Note 40 records excess managerial remuneration of ₹ 0.828 Crore in FY24 under Section 197.
p. 37, p. 41, p. 123, p. 148, p. 185Short-term borrowings of ₹24.60 cr against cash of ₹0.00 cr. Debt that must be refinanced within a year is comfortable only while lenders stay comfortable.
rule: cash < 0.5x short-term debtCompany's Claims vs Reality
We stress-test each claim against the filing's own data.
Audited disclosures under CARO 2020 Clause 3(vii)(a) show persistent delays in depositing undisputed statutory dues (GST and TDS) across all three Fiscals. In FY26, the company had 6 delayed instances totaling ₹ 0.239 Crore, with delays lasting up to 243 days.
p. 23, p. 85Auditors issued negative comments in CARO reports for FY26 and FY25 regarding quarterly bank statement discrepancies against financial books on inventory and receivables. Also, multiple board committees were constituted erroneously, and historical capital filings are untraceable.
p. 42, p. 85, p. 237Most transactions were on an arm's length basis, but the company violated statutory limits under Section 197 of the Companies Act, 2013, by paying ₹ 0.828 Crore in excess managerial remuneration in FY24, which had to be regularized via AGM special resolution on June 28, 2025.
p. 37, p. 150Proprietary SWOT — Company-Specific
Strengths
- One of only five players in India with short-circuit test certification for 500 MVA 400 kV power transformers, creating a high technical barrier to entry.
- RDSO-certified to manufacture 100 MVA Scott traction transformers (132 kV and 220 kV class) for Indian Railways electrification.
- Strong backward integration with indigenous manufacturing of transformer tanks and radiators, optimizing cost and reducing third-party lead time.
Weaknesses
- Weak internal financial controls over inventory valuation and bank filings, as flagged by the auditor.
- Extreme customer concentration (top 10 clients contributed 93.16% of FY26 revenue).
- Heavy dependency on government bids (85.37% of FY26 revenue), exposing it to tender delays and public budget changes.
Opportunities
- National power transmission system expansion driven by the government's target of 500 GW of renewable energy by 2030.
- Capacity expansion and automated backward integration lines at the Gangol facility through IPO proceed utilization.
- Import substitution in EHV (Extra High Voltage) utility and traction transformers.
Threats (material, not boilerplate)
- Risk of debarment or blacklisting by state transmission companies (such as the BSPTCL conditional debarment in early 2026). risk_section
Why it matters: Government clients generate 85.37% of revenue; debarment would freeze its main order pipeline. - Severe raw material price volatility and supply disruptions for copper, CRGO steel, and transformer oil. risk_section
Why it matters: Directly impacts profitability as raw materials comprise the bulk of total operating expenses. - Intense competition in EHV transformer manufacturing from well-capitalized domestic and MNC players like BHEL, CG Power, TRIL, and Hitachi Energy. risk_section
Why it matters: Could squeeze bidding margins and restrict market share growth.
Allotment Status
Check your allotment on the registrar's portal → Registrar: MUFG Intime India
Allotment is decided by the registrar, not by us and not by the exchange. In an oversubscribed retail book, allotment is by lottery, so a large application does not improve your odds beyond one lot. If money stays blocked after the refund date, the mandate expiry (22 Oct 2026) is the date to raise with your bank.
Analyst Q&A: Burning Questions
Facts from the filing. No recommendation — that layer arrives once our Research Analyst registration is live.
Why is the company allocating ₹ 155.00 Crore for incremental working capital and only ₹ 64.18 Crore for capital expenditure when its capacity utilization at Rithani is below 1% and overall total utilization is only 45.99%?
The company's transformer manufacturing is custom-engineered and tender-driven, requiring extended design, test, and manufacturing cycles (six months to two years) which bloat net working capital days (107 days in FY26). The Rithani facility's low utilization (0.25%) is intentional as the company has repurposed Rithani for prototype developments and over 200 short-circuit test certifications. The ₹ 155.00 Crore funding is crucial to execute its rapidly expanding ₹ 1,818.32 Crore order book.
p. 63, p. 131, p. 174, p. 175How severe is the customer concentration risk, and what are the implications of the temporary debarment by BSPTCL in early 2026?
The customer concentration risk is extreme: the top 10 clients contributed 93.16% of FY26 revenue, and government utilities generated 85.37% of revenue. The BSPTCL debarment in February 2026 (for delays and defects in its JV project) was conditionally withdrawn on May 14, 2026, after completing balance punch-point tasks. Any future blacklisting or failure to meet pre-qualification criteria would cut off its primary order pipelines.
p. 14, p. 212What is the primary driver of the company's EBITDA margin expansion from 11.23% in FY24 to 27.59% in FY26, and is this level of profitability sustainable?
Profitability expansion is driven by a structural shift in product mix toward certified EHV (500 MVA 400 kV) power transformers and advanced Scott traction transformers which carry high margins and technical barriers. Gross margins expanded from 28.80% (FY24) to 38.88% (FY26). However, because revenues are tender-driven and raw material input costs are highly volatile (copper, steel), margins remain susceptible to competitive bidding pressures and commodity inflation.
p. 63, p. 125, p. 212What are the key governance risks arising from the missing corporate records, erroneous committee structures, and the massive ~4x spike in promoter remuneration?
The company has serious historic corporate governance and administrative weaknesses: historical capital files are untraceable, and the Board has run with improperly constituted CSR, Audit, and NRC committees (regularized post-facto via RoC applications on Dec 6, 2025). Furthermore, promoter remuneration was increased by ~288% in FY26 to ₹ 1.593 Crore (representing 39.2% of entire employee benefits), indicating aggressive pre-IPO cash extraction that harms public shareholder value.
p. 37, p. 42, p. 123, p. 237What Earlier Investors Paid
Early capital takes real risk and is fairly rewarded for it — a large multiple built over many years is normal. What deserves a closer look is a steep step-up in a short window: a round priced cheaply only months before the offer.
| Shareholder | Priced at | When | vs IPO price |
|---|---|---|---|
| Bonus Issue (7:8) | — | 1989-08-25 | — |
| Bonus Issue (1:4) | — | 1992-07-01 | — |
| Sub-division (1:5) | — | 2025-08-27 | — |
| Bonus Issue (3:1) | — | 2025-09-19 | — |
Prices are as stated in the filing’s allotment history and are not adjusted for later bonus issues or share splits. Where a company has issued bonus shares, the multiples above understate the true return and can even read as losses. Adjusting for that is on our list; until it is done we would rather show the raw disclosure and tell you its limits than publish a confident number that is wrong.
Lock-in Expiry Calendar
Shares held before the IPO cannot be sold immediately; they unlock in tranches. When a tranche unlocks, more shares become eligible to trade. Retail investors are frequently caught unaware by these dates. The schedule below follows from the listing date; quantities are shown only where the filing discloses them.
- 16 Mar 2028Promoters Minimum Contribution18 months
- 16 Mar 2027Promoters Excess Shareholding6 months
An unlock means more shares may be sold — not that they will be, and not that the price will move. We state the dates; what you do with them is your call.
What Changed Between the DRHP and the RHP
Companies file a draft prospectus, then a final one. The changes in between are rarely reported, and they can be revealing.
| Item | In the DRHP | In the RHP / Addendum |
|---|---|---|
| Reporting Period Reporting periods updated to cover the full fiscal year 2026, dropping the interim six-month period ended September 30, 2025 and removing Fiscal 2023 from the face of comparative restated financial statements. | Six-month period ended September 30, 2025, and Fiscals 2025, 2024 and 2023 | Fiscals 2026, 2025, and 2024 (Standalone) |
| Restated Financials Newly audited standalone full-year financials for Fiscal 2026 were fully incorporated into the RHP, while comparative years FY25 and FY24 were carried forward. | Audited financials only up to September 30, 2025 (Revenue of ₹ 165.58 Crore and PAT of ₹ 30.67 Crore for the six months) | Audited full-year standalone financials for Fiscal 2026 included (Revenue of ₹ 653.84 Crore and PAT of ₹ 129.73 Crore) |
| Offer for Sale The total size of the Offer for Sale was reduced by 2,632,085 Equity Shares. K Sons Family Trust remains the sole Promoter Selling Shareholder. Total Fresh Issue size remained identical at ₹ 300.00 Crore. | Up to 14,590,000 Equity Shares of face value of ₹ 2 each by K Sons Family Trust | Up to 11,957,915 Equity Shares of face value of ₹ 2 each by K Sons Family Trust |
| Use of Proceeds Net proceeds allocation was revised: Capital Expenditure decreased by ₹ 2.56 Crore, while funding for Incremental Working Capital increased by ₹ 25.00 Crore to execute the expanding order book. | Capital Expenditure: ₹ 66.74 Crore; Incremental Working Capital: ₹ 130.00 Crore | Capital Expenditure: ₹ 64.18 Crore; Incremental Working Capital: ₹ 155.00 Crore |
| Contingent Liabilities While the reporting date of contingent liabilities moved from September 30, 2025 in the DRHP to March 31, 2026 in the RHP, all major liability and guarantee amounts remained identical. | Evaluated as of September 30, 2025 (Disputed VAT: ₹ 0.65 Crore; Disputed GST: ₹ 0.56 Crore; Disputed Non-tax: ₹ 4.25 Crore; Guarantees: ₹ 324.82 Crore; Capital commitments: ₹ 2.02 Crore) | Evaluated as of March 31, 2026 (Disputed VAT: ₹ 0.65 Crore; Disputed GST: ₹ 0.56 Crore; Disputed Non-tax: ₹ 4.25 Crore; Guarantees: ₹ 324.82 Crore; Capital commitments: ₹ 2.02 Crore) |
| Litigation Disputed tax litigations by the Company rose from 3 to 5 cases, while the overall value decreased due to the resolution of civil cases. Outstanding litigation against the Company rose in aggregate from ₹ 13.11 Crore to ₹ 16.22 Crore. | By Company: 3 tax cases, 2 material civil litigations (₹ 8.71 Crore aggregate); Against Company: 2 tax cases, 2 material civil litigations (₹ 13.11 Crore aggregate) | By Company: 5 tax cases, 1 material civil litigation (₹ 6.15 Crore aggregate); Against Company: 2 tax cases, 2 material civil litigations (₹ 16.22 Crore aggregate) |
| Statutory Dues Audit disclosures were updated with Fiscal 2026 data, showing significantly longer TDS delays (up to 243 days compared to 27 days historically) and larger delayed payment amounts. | 1 instance of GST delay of 7 days (₹ 0.001 Crore) and 2 instances of TDS delays up to 27 days (₹ 0.008 Crore) reported for Fiscal 2025 | 1 instance of GST delay of 30 days (₹ 0.07 Crore) and 5 instances of TDS delays up to 243 days (₹ 0.169 Crore) reported for Fiscal 2026 |
| Promoter Holding Pre-Offer Promoter and Promoter Group holding remained identical at 99.72% of the paid-up Equity Share capital. | K Sons Family Trust holds 72,203,991 Equity Shares (97.00%) and Kanohar International Private Limited holds 2,028,000 Equity Shares (2.72%), collectively holding 99.72% | K Sons Family Trust holds 72,203,991 Equity Shares (97.00%) and Kanohar International Private Limited holds 2,028,000 Equity Shares (2.72%), collectively holding 99.72% |
| Risk Factors Risk factors were comprehensively updated with standalone Fiscal 2026 numbers, the latest supplier concentrations, and the updated order book of ₹ 1,818.32 Crore as of March 31, 2026. | Risk factors presented historical operational figures, capacity utilization, and order books up to September 30, 2025 | Risk factors were updated to reflect standalone full-year Fiscal 2026 figures, capacity utilization (45.99% overall), and the updated order book |
| Statutory Auditor Statutory Auditor identity and terms of appointment remained identical. Predecessor auditors for historical periods (R P S G & Co., etc.) also remained consistent. | S S Kothari Mehta & Company, Chartered Accountants (appointed on February 22, 2025 due to casual vacancy) | S S Kothari Mehta & Company, Chartered Accountants (appointed on February 22, 2025 due to casual vacancy) |
Educational, grounded entirely in the company's filings (DRHP/RHP). Not investment advice. FinMinutes does not provide buy/sell recommendations.